Author

Rebecca Curtis 1

1 Takeda Development Centre Europe Ltd,London,United Kingdom

REAL WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS

Stefan Schreiber, Axel Dignass, Laurent Peyrin-Biroulet, Mahmoud Mosli, Greg Hather, Dirk Demuth, Aimee Blake, Rebecca Curtis, Javaria Mona Khalid, Edward V Loftus Jr

REAL-WORLD PATTERNS OF TREATMENT DISCONTINUATION, FLARES, AND HOSPITALISATIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS WITHIN 12 MONTHS OF INITIATION OF VEDOLIZUMAB OR INFLIXIMAB

Haridarshan Patel, Mireia Raluy Callado, Ariel Berger, Rebecca Curtis, Mona Javaria Khalid

REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

Mireia Raluy Callado, Robert Carroll, Rebecca Curtis, Mona Javaria Khalid, Haridarshan Patel

SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN ADULT ULCERATIVE COLITIS AND CROHN?S DISEASE PATIENTS

Sandra M Bovens, Angela Solaman, Rebecca Curtis, Sharon O'Byrne, Javaria Mona Khalid, Dirk Demuth

Item 1 - 4 / 4
1